Visible light controlled release of anticancer drug through double activation of prodrug

ACS Medicinal Chemistry Letters

Volumn 4, Issue 1, 2013, Pages 124-127

  Hossion, Abugafar M L ^a   Bio, Moses ^a,b   Nkepang, Gregory ^a,b   Awuah, Samuel G ^a,b   You, Youngjae ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

aminoacrylate; anticancer drug; photosensitizer; photounclick; Prodrug; visible near IR

Indexed keywords

ANTINEOPLASTIC AGENT; CA 4; COUMARIN; ESTERASE; FIRTECAN; PRODRUG; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LYSATE; CELL STRAIN MCF 7; CLICK CHEMISTRY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; IC 50; PRIORITY JOURNAL;

EID: 84872298174     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml3003617     Document Type: Article

References (25)

1. Bao, C.; Jin, M.; Li, B.; Xu, Y.; Jina, J.; Zhu, L. Long conjugated 2-nitrobenzyl derivative caged anticancer prodrugs with visible light regulated release: preparation and functionalizations Org. Biomol. Chem. 2012, 10, 5238-5244
2. Kratz, F.; Warnecke, A.; Scheuermann, K.; Stockmar, C.; Schwab, J.; Lazar, P.; Drückes, P.; Esser, N.; Drevs, J.; Rognan, D.; Bissantz, C.; Hinderling, C.; Folkers, G.; Fichtner, I.; Unger, C. Probing the cysteine-34 position of endognous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound J. Med. Chem. 2002, 45, 5523-5533
3. Snyder, J. W.; Greco, W. R.; Bellnier, D. A.; Vaughan, L.; Henderson, B. W. Photodynamic therapy: A means to enhanced drug delivery to tumors Cancer Res. 2003, 63, 8126-8131
4. Ellis, G. A.; McGrath, N. A.; Palte, M. J.; Raines, R. T. Ribonuclease-activated cancer prodrug ACS Med. Chem. Lett. 2012, 3, 268-272
5. Rooseboom, M.; Commandeur, J. N.; Vermeulen, N. P. Enzyme-catalyzed activation of anticancer prodrugs Pharmacol. Rev. 2004, 56, 53-102
6. Rai, P.; Mallidi, S.; Zheng, X.; Rahmanzadeh, R.; Mir, Y.; Elrington, S.; Khurshid, A.; Hasan, T. Development and applications of photo-triggered theranostic agents Adv. Drug Delivery Rev. 2010, 62, 1094
7. Alvarez-Lorenzo, C.; Bromberg, L.; Concheiro, A. Light-sensitive intelligent drug delivery dystems Photochem. Photobiol. 2009, 85, 848-860
8. Katz, J. S. Burdick, Light-responsive biomaterials: development and applications Macromol. Biosci. 2010, 10, 339-348
9. Yu, H.; Li, J.; Wu, D.; Qiu, Z.; Zhang, Y. Chemistry and biological applications of photo-labile organic molecules Chem. Soc. Rev. 2010, 39, 464-473
10. Mayer, G.; Heckel, A. Biologically active molecules with a "light switch" Angew. Chem., Int. Ed. Engl. 2006, 45, 4900-4921
11. Anderson, R. R.; Parrish, J. A. The optics of human skin J. Invest. Dermatol. 1981, 77, 13-19
12. Juzenas, P.; Juzeniene, A.; Kaalhus, O.; Iani, V.; Moan, J. Depth profile of protoporphyrin IX fluorescence in an amelanotic mouse melanoma model J. Photochem. Photobiol. 2009, 85, 760-764
13. Jiang, M. Y.; Dolphin, D. Site-specific prodrug release using visible light J. Am. Chem. Soc. 2008, 130, 4236-4237
14. Zamadar, M.; Ghosh, G.; Mahendran, A.; Minnis, M.; Kruft, B. I.; Ghogare, A.; Aebisher, D.; Greer, A. Photosensitizer drug delivery via an optical fiber J. Am. Chem. Soc. 2011, 133, 7882-7891
15. Ruebner, A.; Yang, Z.; Leung, D.; Breslow, R. A Cyclodextrin dimer with a photocleavable linker as a possible carrier for the photosensitizer in photodynamic tumor therapy Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 14692-14693
16. Bio, M.; Nkepang, G.; You, Y. Click and photo-unclick chemistry of aminoacrylate for visible light-triggered drug release Chem. Commun. 2012, 48, 6517-6519
17. Lovell, J. F.; Liu, T. W.; Chen, J.; Zheng, G. Activatable photosensitizers for imaging and therapy Chem. Rev. 2010, 110, 2839-2857
18. Kobayashi, H.; Ogawa, M.; Alford, R.; Choyke, P. L.; Urano, Y. New strategies for fluorescent probe design in medical diagnostic imaging Chem. Rev. 2010, 110, 2620-2640
19. Takemoto, K.; Matsuda, T.; McDougall, M.; Kaubert, D. H.; Hasegawa, A.; Los, G. V.; Wood, K. V.; Miyawaki, A.; Nagai, T. Chromophore-assisted light inactivation of halo tag fusion proteins labeled with eosin in living cells ACS Chem. Biol. 2011, 6, 401-406
20. Ramesh, M.; Ahlawat, P.; Srinivas, N. R. Irinotecan and its active metabolite, SN-38: review of bioanalytical methods and recent update from clinical pharmacology perspectives Biomed. Chromatogr. 2010, 24, 104-123
21. Nagaiah, G.; Remick, S. C. Combretastatin A4 phosphate: a novel vascular disrupting agent Future Oncol. 2010, 6, 1219-1228
22. Neises, B.; Steglich, W. Esterification of carboxylic acids with dicyclohexylcarbodiimide/4-dimethylaminopyridine: tert -butyl ethyl fumarate. Organic Syntheses; Wiley & Sons: New York, 1990; Vol. 7, pp 93.
23. Skovsen, E.; Snyder, J. W.; Lambert, J. D.; Ogilby, P. R. Lifetime and diffusion of singlet oxygen in a cell J. Phys. Chem. B 2005, 109, 8570-8573
24. Niedre, M.; Patterson, M. S.; Wilson, B. C. Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo Photochem. Photobiol. 2002, 75, 382-391
25. Moan, J. On the diffusion length of singlet oxygen in cells and tissues J. Photochem. Photobiol., B: Biol. 1990, 6, 343-347